Novel Therapies and Diagnostic Methods (National Cancer Institute): Difference between revisions

From Beacon
No edit summary
Line 6: Line 6:
{| class="wikitable"
{| class="wikitable"
! Radiology !!  !!  !!  
! Radiology !!  !!  !!  
|-
|-  
| '''Type''' || '''Name''' || '''Availibility''' || '''Uses per year'''
| '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
|-
|-  
| Machine || CT scanners || Yes ||  
| Machine || CT scanners || yes ||  
|-
|-  
| Machine || MRI (specify the strength and field of the techniques) || Yes ||  
| Machine || MRI (specify the strength and field of the techniques) || yes ||  
|-
|-  
| Machine || Mammography (please specify analogic mammography or digital) || Yes/Digital || 9580 (2022)
| Machine || Mammography (please specify analogic mammography or digital) || yes || digital / 9580 (2022)
|-
|-  
| Machine || Ultrasound || Yes ||  
| Machine || Ultrasound || yes ||  
|-
|-  
| Machine || Gamma Camera || Yes ||  
| Machine || Gamma Camera || yes ||  
|-
|-  
| Technique || MRI-guided biopsy || Yes ||  
| Technique || MRI-guided biopsy || yes ||
|-
|-
| Technique || Endoscopic retrograde cholangiopancreatography (ERCP) || Yes ||  
| Technique || Ultrasound guided biopsy || yes ||  
|-
|-  
| Technique || E/S Fine-needle biopsy || Yes ||  
| Technique || Endoscopic retrograde cholangiopancreatography (ERCP) || yes ||
|-
|-
| Technique || Angiography || Yes ||  
| Technique || EBUS-TBNA || yes ||  
|-
|-  
! Nuclear Medicine !!  !!  !!
| Technique || E/S Fine-needle biopsy || yes ||  
|-
|-  
| Type || Name || Availibility || Uses per year
| Technique || Angiography || yes ||  
|-
|-  
| Machine || Pet Scan || Yes ||  
! Nuclear Medicine !!  !!  !!  
|-
|-  
| Machine || PET CT || Yes ||  
| '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
|-
|-  
| Machine || PET/MRI || Yes ||  
| Machine || Pet Scan || yes ||  
|-
|-  
| Facility || Radionuclide treatment facilities || Yes ||  
| Machine || PET CT || yes ||  
|-
|-  
| Machine || SPECT || Yes ||  
| Machine || PET/MRI || yes ||  
|-
|-  
| Machine || SPECT CT || Yes ||  
| Facility || Radionuclide treatment facilities || yes ||  
|-
|-  
| Technique || Bone scintigraphy || Yes || 5158 (2022)
| Machine || SPECT || yes ||  
|-
|-  
| Machine || SPECT CT || yes ||  
|-  
| Technique || Bone scintigraphy || yes || 5158 (2022)
|-  
! Pathology !!  !!  !!  
! Pathology !!  !!  !!  
|-
|-  
| '''Type''' || '''Name''' || '''Availibility''' || '''Uses per year'''
| '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
|-
|-  
| Facility || Cytology laboratory || Yes || 8715 (2022)
| Facility || Cytology laboratory || yes || 8715 tests (2022)
|-
|-  
| Facility || Histopathology laboratory || Yes ||  
| Facility || Histopathology laboratory || yes ||
|-
|-
| Technique || FISH (Fluorescence In Situ Hybridization) || Yes ||  
| Technique || Comparative Genomic Hybridization (CGH) || yes ||  
|-
|-  
| Technique || PCR (Polymerase Chain Reaction) || Yes ||  
| Technique || FISH (Fluorescence In Situ Hybridization) || yes ||  
|-
|-  
| Technique || Cytometry || Yes ||  
| Technique || PCR (Polymerase Chain Reaction) || yes ||  
|-
|-  
| Technique || Liquid biopsy || Yes ||  
| Technique || Cytometry || yes ||  
|-
|-  
| Technique || Techniques for molecular pathology || Yes ||  
| Technique || Liquid biopsy || yes ||
|-
|-
! Pathology: Molecular Tests !!  !!  !!
| Technique || Immunofluorescence techniques || yes ||
|-
|-
| '''Type''' || '''Name''' || '''Availibility''' || '''Uses per year'''
| Technique || Histochemistry || yes ||  
|-
|-  
| Technique || PDL1 || Yes ||  
| Technique || Techniques for molecular pathology || yes ||
|-
|-
| Technique || PI3KCA || Yes || 18 (2022)
| Technique || Cytogenetics || yes ||  
|-
|-  
| Technique || KRAS || Yes ||  
! Pathology: Molecular Tests !!  !!  !!  
|-
|-  
| Technique || BRAF || Yes || 106 (2022)
| '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
|-
|-  
| Technique || EGFR || Yes || 71 (2022)
| Technique || PDL1 || yes ||  
|-
|-  
| Technique || ALK || Yes ||  
| Technique || PI3KCA || yes || 18 (2022)
|-
|-  
| Technique || ROS || Yes ||  
| Technique || KRAS || yes ||  
|-
|-  
| Technique || HER2 status || Yes ||  
| Technique || BRAF || yes || 106 (2022)
|-
|-  
! Others !!  !!  !!
| Technique || EGFR || yes || 71 (2022)
|-
|-  
| '''Type''' || '''Name''' || '''Availibility''' || '''Uses per year'''
| Technique || ALK || yes ||  
|-
|-  
| Technique || Bronchoscopy || Yes ||  
| Technique || ROS || yes ||  
|-
|-  
| Technique || Colposcopy || Yes ||  
| Technique || HER2 status || yes ||
|-
|-
| Technique || Colonoscopy || Yes || +1000 (yearly)
| Technique || COMPREHENSIVE MOLECULAR PANELS || yes ||  
|-
|-  
| Technique || Hysteroscopy || Yes ||  
! Others !!  !!  !!  
|-  
| '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
|-  
| Technique || Bronchoscopy || yes ||  
|-  
| Technique || Colposcopy || yes ||  
|-  
| Technique || Colonoscopy || yes || >1000 (yearly)
|-  
| Technique || Hysteroscopy || yes ||  
|}
|}


Revision as of 18:30, 19 September 2024

Go back to National Cancer Institute page

Diagnostics

Radiology
Type Name Availability Uses per year
Machine CT scanners yes
Machine MRI (specify the strength and field of the techniques) yes
Machine Mammography (please specify analogic mammography or digital) yes digital / 9580 (2022)
Machine Ultrasound yes
Machine Gamma Camera yes
Technique MRI-guided biopsy yes
Technique Ultrasound guided biopsy yes
Technique Endoscopic retrograde cholangiopancreatography (ERCP) yes
Technique EBUS-TBNA yes
Technique E/S Fine-needle biopsy yes
Technique Angiography yes
Nuclear Medicine
Type Name Availability Uses per year
Machine Pet Scan yes
Machine PET CT yes
Machine PET/MRI yes
Facility Radionuclide treatment facilities yes
Machine SPECT yes
Machine SPECT CT yes
Technique Bone scintigraphy yes 5158 (2022)
Pathology
Type Name Availability Uses per year
Facility Cytology laboratory yes 8715 tests (2022)
Facility Histopathology laboratory yes
Technique Comparative Genomic Hybridization (CGH) yes
Technique FISH (Fluorescence In Situ Hybridization) yes
Technique PCR (Polymerase Chain Reaction) yes
Technique Cytometry yes
Technique Liquid biopsy yes
Technique Immunofluorescence techniques yes
Technique Histochemistry yes
Technique Techniques for molecular pathology yes
Technique Cytogenetics yes
Pathology: Molecular Tests
Type Name Availability Uses per year
Technique PDL1 yes
Technique PI3KCA yes 18 (2022)
Technique KRAS yes
Technique BRAF yes 106 (2022)
Technique EGFR yes 71 (2022)
Technique ALK yes
Technique ROS yes
Technique HER2 status yes
Technique COMPREHENSIVE MOLECULAR PANELS yes
Others
Type Name Availability Uses per year
Technique Bronchoscopy yes
Technique Colposcopy yes
Technique Colonoscopy yes >1000 (yearly)
Technique Hysteroscopy yes

Treatment

Surgical Oncology
Type Name Availibility Uses per year
Specialist Breast surgery Yes 678 (2022)
Specialist Urological surgery Yes 428 (2022)
Specialist Thoracic surgery Yes
Specialist Digestive surgery Yes 585 (2022)
Specialist Gynaecological surgery Yes 362 (2022)
Specialist Head and neck surgery Yes 99 (2022)
Specialist Soft tissue surgery Yes
Specialist Sarcoma surgery Yes
Technique Video-assisted thoracoscopy Yes
Radiotherapy
Type Name Availibility Uses per year
Facility Total MegaVoltage units 4 +51000 (yearly)
Machine Linear accelerators Yes
Machine Linear accelerators with IMRT/VMAT Yes 31125 (2022)
Machine Linear accelerators with IGRT Yes
Machine Linear accelerators with SBRT/SRS Yes
Machine Dedicated SRS units Yes
Machine Cobalt Units Yes
Machine Brachytherapy unit Yes 720 (yearly)
Technique Intraperitoneal chemo-hyperthermia ( HIPEC) Yes
Technique Stereotactic radiotherapy Yes
Technique Chemoembolization Yes
Technique Total Body Irradiation (TBI) Yes
Technique 3D conformal radiotherapy Yes
Technique Radiosurgery Yes
Technique CT planning Yes
Technique IMRT radiotherapy planning system Yes 1910 (2022)
Technique Magnetic resonance for radiotherapy treatment planning Yes
Technique PET CT treatment planning Yes
Hemato-Oncology / Bone Marrow Transplants
Type Name Availibility Uses per year
Facility Transfusion Unit Yes
Facility Cellular therapy unit with GMP (Good Manufacturing Practice) Yes
Specialists
Type Name Availibility Uses per year
Specialist Physician with a specialisation in palliative care Yes
Specialist Medical oncologist Yes
Specialist Physician specialised in pain treatment Yes
Specialist Radiotherapist 16
Specialist Psychologist or Psychotherapist 3
Specialist Psychiatrist 1
Specialist Social worker 1
Specialist Physiotherapist Yes
Specialist Dietitian 1
Others
Type Name Availibility Uses per year
Facility 24-hour Oncological Emergency Department Yes 1519 (2022)
Technique Interventional Endoscopy Yes
Technique Nephrostomy Yes
Facility Clinical Trial Center Yes
Facility Phase 1 Clinical Trial Unit Yes
Technique Intraperitoneal Chemotherapy with Pressurized Air Flow (PIPAC) Yes

Prevention

Screening and Others
Type Name Availibility Uses per year
Facility Breast cancer screening program Yes
Facility Cervical cancer screening program Yes
Facility Colorectal cancer screening program Yes

Palliative Care

Palliative Care
Type Name Availibility Uses per year
Facility Home palliative care availability Yes
Retrieved from "https://wiki.beaconcancer.org/index.php?title=Novel_Therapies_and_Diagnostic_Methods_(National_Cancer_Institute)&oldid=24204"
Powered by MediaWiki
Powered by Semantic MediaWiki